Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
Author(s) -
Karine Provost,
Leonardo Iaccarino,
David N. SoleimaniMeigooni,
Suzanne L. Baker,
Lauren Edwards,
Udo Eichenlaub,
Oskar Hansson,
William J. Jagust,
Mustafa Janabi,
Renaud La Joie,
Orit H. LesmanSegev,
Taylor J. Mellinger,
Bruce L. Miller,
Rik Ossenkoppele,
Julie Pham,
Ruben Smith,
Ida Sonni,
Amelia Strom,
Niklas Mattsson,
Gil D. Rabinovici
Publication year - 2021
Publication title -
european journal of nuclear medicine and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.313
H-Index - 163
eISSN - 1619-7089
pISSN - 1619-7070
DOI - 10.1007/s00259-020-05152-8
Subject(s) - pet imaging , medicine , nuclear medicine , positron emission tomography
To compare rates of tau biomarker positivity (T-status) per the 2018 Alzheimer's Disease (AD) Research Framework derived from [ 18 F]flortaucipir (FTP) PET visual assessment, FTP quantification, and cerebrospinal fluid (CSF) phosphorylated Tau-181 (PTau181).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom